Skip to main content
. 2022 May 31;13:879686. doi: 10.3389/fimmu.2022.879686

Table 1.

Clinical characteristics and demographics.

n 64
Median Age (range) 59 (24-96)
Male (%) 34 (53%)
Race (%)
White or Caucasian 48 (75%)
Black or African American 13 (20%)
Hispanic 1 (2%)
Not recorded 2 (3%)
Weight (Kg) 99.8 (41-190)
BMI median (range) 35.6 (17.2-66.1)
Comorbidity
Obesity, patient number (%) 42 (66%)
Hypertension, patient number (%) 39 (61%)
Diabetes Mellitus, patient number (%) 26 (41%)
Coronary artery disease/arrhymia/CHF, patient number (%) 20 (31%)
Underlying lung disease, patient number (%) 21 (33%)
Chronic kidney disease, patient number (%) 7 (11%)
Hyperlipidemia, patient number (%) 14 (22%)
Hospital Day Neutrophils Obtained
mean/median (range)
8.5/6.5 (1-36)
Laboratory Values
WBC/Neutrophil (4.1-10.8 x103/μL) mean/median 13.6/11.7
NLR mean/median 20.5/12.5
d-dimer (0.19-0.74 μg/ml FEU) 423, range 0.37-15,107 (n=40)
Ferritin (7-350 ng/ml) 711, range 71-7500 (n=34)
C-reactive protein (<3.0 mg/L) 177, range 2.6-380 (n=30)
Hospital Course
APACHE 21, range 6-38
ICU, patient number (%) 59 (92%)
Ventilator, patient number (%) 57 (89%)
ECMO, patient number (%) 6 (9%)
Dialysis, patient number (%) 16 (25%)
Died, patient number (%) 32 (50%)
Discharge Home, patient number (%) 9 (14%)
Discharge to LTC, patient number (%) 22 (34%)
Treatment
Remdesivir, patient number (%) 48 (75%)
Corticosteroids, patient number (%) 59 (92%)
Monoclonal antibody or Convalescent Plasma, patient number (%) 29 (45%)